FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DeFord John A
2. Issuer Name and Ticker or Trading Symbol

BARD C R INC /NJ/ [ BCR ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Sr. VP Sci Tech and Clin Afrs
(Last)          (First)          (Middle)

C/O C. R. BARD, INC., 730 CENTRAL AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

12/20/2017
(Street)

MURRAY HILL, NJ 07974
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   12/20/2017     M (1)    4161.0000   A $136.3700   20950.2316   (2) D    
Common Stock   12/20/2017     M (1)    3767.0000   A $168.8650   24717.2316   D    
Common Stock   12/20/2017     M (1)    3293.0000   A $186.4250   28010.2316   D    
Common Stock   12/20/2017     M (1)    2886.0000   A $219.5550   30896.2316   D    
Common Stock   12/20/2017     S (1)    900.0000   D $334.1189   (3) 29996.2316   D    
Common Stock   12/20/2017     S (1)    13207.0000   D $333.4341   (4) 16789.2316   D    
Common Stock                  83.8200   (5) I   401(k) Plan  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (Right to Buy)   (6) $186.4250   12/20/2017     M         3293.0000      (7) 12/9/2025   Common Stock   3293.0000   $0.0000   6586.0000   D    
Option (Right to Buy)   (6) $168.8650   12/20/2017     M         3767.0000      (8) 12/10/2024   Common Stock   3767.0000   $0.0000   3768.0000   D    
Option (Right to Buy)   (6) $136.3700   12/20/2017     M         4161.0000      (9) 12/11/2023   Common Stock   4161.0000   $0.0000   0.0000   D    
Option (Right to Buy)   (6) $219.5550   12/20/2017     M         2886.0000      (10) 12/14/2026   Common Stock   2886.0000   $0.0000   8658.0000   D    

Explanation of Responses:
(1)  Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
(2)  Includes 0.0887 shares acquired under the Company's Dividend Reinvestment Plan from February 4, 2017 to August 4, 2017. Includes 0.0020 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017.
(3)  Represents the weighted average sales price for price increments ranging from $333.97 to $334.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
(4)  Represents the weighted average sales price for price increments ranging from $332.96 to $333.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
(5)  Includes 3.904 shares acquired under the Company's 401(k) Plan from May 4, 2017 to August 4, 2017.
(6)  Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
(7)  Of this option grant 3,293 options vested on December 9, 2017 and the remaining options vest in two annual installments beginning on December 9, 2018.
(8)  Of this option grant 3,767 options vested on December 10, 2017 and the remaining options vest on December 10, 2018.
(9)  Options vested on December 11, 2017.
(10)  Of this option grant 2,886 options vested on December 14, 2017 and the remaining options vest in three annual installments beginning on December 14, 2018.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DeFord John A
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL, NJ 07974


Sr. VP Sci Tech and Clin Afrs

Signatures
Myra McGinley, Attorney-in-Fact 12/22/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Bard C R (NYSE:BCR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bard C R Charts.
Bard C R (NYSE:BCR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bard C R Charts.